Sensus Healthcare, Inc. (SRTS) vs Talis Biomedical Corporation (TLIS)

Sensus Healthcare, Inc. and Talis Biomedical Corporation are both Medical Devices companies. Sensus Healthcare, Inc. and Talis Biomedical Corporation are of similar size ($47.9M and $46.3M). Sensus Healthcare, Inc. grew revenue faster over the last twelve months: −53.4% against −65.2%. Talis Biomedical Corporation has the higher net margin (0.00% vs −88.5%) and the higher return on invested capital (0.00% vs −38.2%). Across the 17 metrics below, Talis Biomedical Corporation leads on 9 and Sensus Healthcare, Inc. on 8.

Valuation

Metric SRTS TLIS Medical Devices median
P/E n/m n/m 22.18
P/S 2.76 5.23 2.70
P/B 1.31 0.11 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 1.01 11.78
EV/Sales 1.94 (55.30) 2.38
Earnings yield (31.97%) (986.62%) (8.22%)
Free cash flow yield (14.40%) (775.19%) (7.80%)

Profitability

Metric SRTS TLIS Medical Devices median
Gross margin 36.39% 97.27% 56.01%
Operating margin (75.72%) 0.00% (15.03%)
Net margin (88.45%) 0.00% (20.40%)
Free cash flow margin (39.82%) 0.00% (7.24%)
Return on equity (34.83%) (70.48%) (15.32%)
Return on assets (30.94%) (52.13%) (19.72%)
Return on invested capital (38.22%) 0.00% (10.33%)

Growth

Metric SRTS TLIS Medical Devices median
Revenue growth (TTM) (53.39%) (65.21%) 8.80%
EPS growth (last fiscal year) (214.63%) 46.33% —
Revenue growth, 5-year CAGR 23.47% (2.24%) 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SRTS TLIS Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 8.71 7.76 2.50
Net debt to EBITDA 2.28 1.16 0.49

Dividend

Metric SRTS TLIS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric SRTS TLIS Medical Devices median
Market cap 47.90m 46.27m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack